| Name | Title | Contact Details |
|---|
CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.
Established in 2019 when Anne Arundel Medical Center and Doctors Community Medical Center came together to form one health system, Luminis Health is sparking a new path forward. With 595 beds across three hospitals, we currently serve seven counties in the heart of central Maryland. Our team is made up of more than 9,000 medical staff, employees and volunteers – all of whom are committed to illuminating new possibilities in health care and for our community. Thanks to them, U.S. News & World Report has deemed AAMC a top hospital in the region and the Maryland Institute for Emergency Medical Services Systems has named DCMC a primary stroke center – just to name a few accolades. We have also earned national recognition in cancer care, stroke care, innovation and patient satisfaction. We can`t wait to see what`s next.
Parastar is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DIGITAL HEALTH. UNLOCKED. Join the journey to transform the worlds health. Healthcare is in the middle of a digital revolution, yet the digital health market is unregulated. As the global leader in providing access to trusted digital health technologi...
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.